SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-026666
Filing Date
2024-02-07
Accepted
2024-02-07 16:05:50
Documents
4
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 6-K d758623d6k.htm 6-K 9776
2 EX-99.1 d758623dex991.htm EX-99.1 110379
3 GRAPHIC g758623dsp4.jpg GRAPHIC 4399
4 GRAPHIC g758623dsp5.jpg GRAPHIC 1781
  Complete submission text file 0001193125-24-026666.txt   129976
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 24604289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)